Form 4: Edwards Lifesciences Executive Sells Shares
Insider Transaction (Form 4)
Wayne Markowitz, CVP, JAPAC of Edwards Lifesciences Corp, sold 9,628 shares of common stock on July 28, 2026 for $85.06 per share.
Summary
- Option exercise/conversion: acquired 9,628 Common Stock at $74.02 ($712,665) on July 28, 2026; holds 31,308 after (Direct).
- Open-market sale: disposed of 9,628 Common Stock at $85.06 ($818,958) on July 28, 2026; holds 21,680 after (Direct).
- Option exercise/conversion: disposed of 9,628 Employee Stock Option (Right to Acquire) on July 28, 2026; holds 9,628 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $818,958 of stock on the open market.
Insider Transactions
Wayne Markowitz — Officer (CVP, JAPAC)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-28 | Option exercise/conversion | Common Stock | 9,628 | $74 | $712.7K | 31,307.871 |
| 2026-07-28 | Open-market sale | Common Stock | 9,628 | $85 | $819.0K | 21,679.871 |
| 2026-07-28 | Option exercise/conversion | Employee Stock Option (Right to Acquire) | 9,628 | — | — | 9,628 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-28 | Option exercise/conversion (9,628 shares) |
| 2026-07-28 | Open-market sale (9,628 shares) |
| 2026-07-28 | Option exercise/conversion (9,628 shares) |
Keywords
insider transaction, Form 4, EW, Edwards Lifesciences Corp, bearish, Wayne Markowitz
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.